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Dear Editor,
The recent paper from Leonardi and La Rosa (2010) aimed to 
establish the prevalence of celiac disease (CD) in patients with 
chronic hepatitis B (HBV) infection (1). Previous studies suggest 
that  chronic  hepatitis  C  (HCV)  could  trigger  immunological 
gluten intolerance in susceptible patients (2). This hypothesis, 
however, is not yet supported by sufficient scientific evidence. 
Similarly, the possible induction of CD in patients treated with 
interferon (IFN) therapy is supported in literature only by case 
reports (3). Moreover, CD affects as much as 1% of the general pop-
ulation (4), and it is possible that the association described in 
some papers is the result of incidental findings in a population 
most studied for the underlying disease. Although the study by 
Leonardi and La Rosa (2010) was unable to disclose any associa-
tion between CD and HBV infection, it represents an interesting 
starting point. The study does have some limitations, particu-
larly a small sample size, a very young average age of partici-
pants, and an overrepresentation of men in the sample. In fact, a 
typical population affected with CD is mostly made up of young 
adults, with twice as many women as men. In this more typical 
population, a diagnosis of CD is made according to the presence 
of EMA and antitransglutaminase IgA in the blood and then an 
intestinal biopsy. The relationship between CD and hepatitis vi-
ruses is intriguing. Previous studies have indicated a defective 
response to the hepatitis B vaccine in CD. It has been postulated 
that a primary role of human leukocyte antigen (HLA) genotype 
DQ2 is that it is predisposed to low immunity to recombinant 
hepatitis B vaccine (5). Other studies have postulated a possible 
role of gluten intake at the time of vaccination (6). Therefore a 
larger study should be designed to investigate the prevalence 
of CD in individuals with HBV and HCV and the possible activa-
tion of CD with IFN therapy. Such a study should also include an 
analysis of the HLA genotype, which seems to have a principal 
role in this association.
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